Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03636100 · ClinicalTrials.gov registry record
Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)
A clinical trial, sponsored by Saint Luke's Health System.
- Terminated
- Registry status
- 7
- Enrollment target
NCT03636100 is a clinical trial that was terminated before completion, run by Saint Luke's Health System. The registered enrollment target is 7 participants.
The verdict
NCT03636100 was terminated before completion, sponsored by Saint Luke's Health System.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Determine whether the presence of acetylcholine in the systemic circulation, correlates with the hypotensive response observed during the thaw phase of cryoballoon ablation.
Interventions
- DEVICE Cryoballoon ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-08-15 |
| Est. Completion | 2019-10-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03636100
The ClinicalTrials.gov registry entry for NCT03636100 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cryoballoon ablation is the first listed.
NCT03636100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03636100 about?
NCT03636100 is a clinical study titled "Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)". Determine whether the presence of acetylcholine in the systemic circulation, correlates with the hypotensive response observed during the thaw phase of cryoballoon ablation.
What is the current status of trial NCT03636100?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2018-08-15. Estimated completion is 2019-10-11.
What interventions are being tested in trial NCT03636100?
The interventions under investigation include: Cryoballoon ablation (DEVICE).
Who is sponsoring clinical trial NCT03636100?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.